{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:36:59Z","timestamp":1793137019106,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ijcard.2022.03.013","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T20:56:26Z","timestamp":1646859386000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study"],"prefix":"10.1016","volume":"354","author":[{"given":"Emanuele","family":"Monda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lioncino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palmiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapaola","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Verrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Mazzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Moscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Dongiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pacileo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.ijcard.2022.03.013_bb0005","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and Management of Hypertrophic Cardiomyopathy of the european Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijcard.2022.03.013_bb0010","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1177\/2047487319888596","article-title":"Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism","volume":"27","author":"Esposito","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2022.03.013_bb0015","article-title":"Hypertrophic cardiomyopathy in children: pathophysiology, diagnosis, and treatment of non-sarcomeric causes","volume":"25","author":"Monda","year":"2021","journal-title":"Front. Pediatr."},{"issue":"299","key":"10.1016\/j.ijcard.2022.03.013_bb0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2019.06.073","article-title":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","volume":"15","author":"Limongelli","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2022.03.013_bb0025","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.3390\/ijms21186682","article-title":"The hidden fragility in the heart of the athletes: a review of genetic biomarkers","volume":"21","author":"Barretta","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ijcard.2022.03.013_bb0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/2047487320934265","article-title":"Yield and clinical significance of genetic screening in elite and amateur athletes","volume":"28","author":"Limongelli","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2022.03.013_bb0035","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/genes11080947","article-title":"Combined PTPN11 and MYBPC3 gene mutations in an adult patient with Noonan syndrome and hypertrophic cardiomyopathy","volume":"11","author":"Caiazza","year":"2020","journal-title":"Genes (Basel)"},{"issue":"18","key":"10.1016\/j.ijcard.2022.03.013_bb0040","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.3390\/ijms21186462","article-title":"Molecular basis of inflammation in the pathogenesis of cardiomyopathies","volume":"21","author":"Monda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"318","key":"10.1016\/j.ijcard.2022.03.013_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2020.08.054","article-title":"The hospitalizations in hypertrophic cardiomyopathy: \"The dark side of the moon\"","volume":"1","author":"Monda","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.03.013_bb0050","article-title":"Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors","author":"Monda","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.013_bb0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2022.03.013_bb0060","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.541","article-title":"Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives","volume":"18","author":"Ammirati","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.013_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.amjcard.2012.04.051","article-title":"\u03b2 blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy","volume":"110","author":"Nistri","year":"2012","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.013_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11886-020-1258-x","article-title":"Targeted medical therapies for hypertrophic cardiomyopathy","volume":"22","author":"Fumagalli","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"issue":"3","key":"10.1016\/j.ijcard.2022.03.013_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population","volume":"3","author":"Siontis","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"17","key":"10.1016\/j.ijcard.2022.03.013_bb0080","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.013_bb0085","first-page":"431","article-title":"Bisoprolol in the treatment of chronic heart failure","volume":"3","author":"de Groote","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"issue":"2_suppl","key":"10.1016\/j.ijcard.2022.03.013_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/2047487320951109","article-title":"Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers","volume":"27","author":"Cattadori","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2022.03.013_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.hfc.2021.01.003","article-title":"Combined effect of Mediterranean diet and aerobic exercise on weight loss and clinical status in obese symptomatic patients with hypertrophic cardiomyopathy","volume":"17","author":"Limongelli","year":"2021","journal-title":"Heart Fail. Clin."},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.013_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"5","key":"10.1016\/j.ijcard.2022.03.013_bb0105","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/genes11050524","article-title":"Genotype-phenotype correlation: a triple DNA mutational event in a boy entering sport conveys an additional pathogenicity risk","volume":"11","author":"Limongelli","year":"2020","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.ijcard.2022.03.013_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jmoldx.2013.07.008","article-title":"DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies","volume":"16","author":"D'Argenio","year":"2014","journal-title":"J. Mol. Diagn."},{"issue":"25","key":"10.1016\/j.ijcard.2022.03.013_bb0115","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the american College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.03.013_bb0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.CIR.35.5.847","article-title":"Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade","volume":"35","author":"Cohen","year":"1967","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.03.013_bb0125","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.38.5.846","article-title":"Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol","volume":"38","author":"Flamm","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.03.013_bb0130","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/hrt.32.6.804","article-title":"Long-term propranolol therapy in muscular subaortic stenosis","volume":"32","author":"Adelman","year":"1970","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2022.03.013_bb0135","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/hrt.44.5.488","article-title":"Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy","volume":"44","author":"Thompson","year":"1980","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2022.03.013_bb0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000175883","article-title":"Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy","volume":"82","author":"Tendera","year":"1993","journal-title":"Cardiology"},{"issue":"25","key":"10.1016\/j.ijcard.2022.03.013_bb0145","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.03.013_bb0150","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with \u03b2-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.ijcard.2022.03.013_bb0155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2022.03.013_bb0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US Nationwide inpatient database, 2003\u20132011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"10253","key":"10.1016\/j.ijcard.2022.03.013_bb0165","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322003321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322003321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:56:37Z","timestamp":1759092997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322003321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":33,"alternative-id":["S0167527322003321"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.013","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}